M.A. Clinical Psychology
College of Science & Mathematics
Bethany Raiff, Ph.D.
Committee Member 1
Tom Dinzeo, Ph.D.
Committee Member 2
Katherine Gotham, Ph.D.
opioid addiction treatment, contingency management, mood
Opioid abuse; Patients--Psychology
Psychiatry and Psychology
Opioid use results in potentially devastating consequences, but medications for opioid use disorder, such as buprenorphine, serve as effective ways to curb cravings and withdrawal, helping an individual reduce their use. Unfortunately, around half of patients discontinue buprenorphine treatment within 30 days and co-occurring conditions such as mood symptoms may serve as additional barriers and decrease engagement. This study sought to examine contingency management (CM; incentives for meeting behavioral goals) as a potential intervention to increase early treatment engagement, as well as the role of total depression, anxiety, and stress (mood) severity in the efficacy of contingency management. New patients with opioid use disorder (n = 47) were recruited from an outpatient opioid clinic and were randomized to receive either treatment as usual (TAU), which consisted of routine clinic care, or CM, which consisted of routine clinic care with a $50 incentive for attending their first follow-up visit. The CM group was almost three times as likely to attend their follow-up appointment as the TAU group, and mood symptom severity did not appear to impact CM efficacy. This study supports CM as a potential way to increase early treatment engagement for patients with a range of mood symptom severity, making recovery more likely and improving quality of life.
Goodwin, Shelby Renee, "CONTINGENCY MANAGEMENT FOR OPIOID USE DISORDER: EARLY TREATMENT ADHERENCE AND MOOD" (2023). Theses and Dissertations. 3116.